secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2022-03-23T23:59:59+00:00
Accession:  0001104659-22-037020
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech raises $10M in registered direct offering at $3.65/share
----------------------------------------------------------------------

- Gross proceeds of $10.0M from sale of 2,739,727 common shares or equivalents at $3.65/share.
- Concurrent private placement of warrants to purchase 2,739,727 shares at $3.52, exercisable immediately for 5.5 years.
- Offering expected to close March 24, 2022; net proceeds for working capital and general corporate purposes.
- Terminated equity distribution agreement with RBC Capital Markets; $2.94M raised under that agreement through termination.
- H.C. Wainwright acted as exclusive placement agent with 7% cash fee and 191,780 placement agent warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922037020/0001104659-22-037020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922037020/tm2210153d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-037020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer